Analysis of:
Vaccines: What Does Cervical Cancer Have To Do With Chickenpox? (blogs.wsj.com)
The article discusses current problems with the apparent short life of the chicken pox vaccine and mandatory vaccinations.
Analysis of:
Wal-Mart And Partners Create Health-IT Research Center (informationweek.com)
Wal-Mart has teamed with the University of Arkansas and Blue Cross Blue Shield to create a new health IT research center
Its goals are to reduce medical errors and increase the efficiency of health care supply.
Analysis of:
Study: Half of U.S. adults at high risk for vision loss not receiving eye exams (www.osnsupersite.com)
30,000 people over age 18 surveyed
Researchers estimated that 61 million Americans are at high risk for vision loss and, of these just more than 50% visited an eye doctor or had a dilated eye exam in the past year.
African Americans and Hispanic persons were significantly less likely to visit an...
Analysis of:
Global Rate of TB Infections Levels Off (online.wsj.com)
Global rates of TB infection appear to be leveling. AIDS associated and drug resistant forms of TB may be on the rise.
Analysis of:
Keppra® Approved For US Epilepsy Patients With One Of The Most Debilitating Seizure Types (www.medicalnewstoday.com)
Keppra has received FDA approval for adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy (IGE). This is Keppra’s third approved indication.
Analysis of:
Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients (www.medicalnewstoday.com)
The Impliant TOPS-on-Fusion (TM) device has received CE Mark approval.The system allows the surgeon to avoid fusing 2 levels.
Analysis of:
FDA Clears Rapid Test for Meningitis (www.fda.gov)
Bacterial meningitis is a life threating condition, which must be distinguished from the less serious viral meningitis. The Xpert EV test has been approved by the FDA.
Analysis of:
FDA Issues Warning on Sleeping Pills (www.nytimes.com)
The article reports on a new FDA warning pertaining to prescription sleep medications.Medications to promote sleep are widely prescribed.New FDA warning could impact prescribing practices
Analysis of:
U.S.extends review of Endo-Vernalis drug to August (today.reuters.com)
FDA is evaluating Frova for a new indicationThis could lead to more prescriptions for all triptansThis could improve Frova's market share
Analysis of:
Experts Seek Options on Painkiller Abuse (www.topix.net)
The article discusses the problem of pain medication abuse and briefly mentions several treatments under research.